1
Orphan Designations
0 approved, 1 designated
0
FDA Approvals
1
Active Trials
200 recruiting
4
Rare Diseases
across 7 areas
1
News (30d)
Innate Pharma is a company with 1 orphan drug designation across 4 rare diseases. Active clinical trials in 1 indication. 1 active policy bill affects their portfolio. 1 news article in the past 30 days.
Disease-by-disease pipeline progression from orphan designation through clinical trials to FDA approval.
Source: FDA Orphan Drug Designations, ClinicalTrials.gov, Drugs@FDA
| Disease | Drug(s) | Stage |
|---|---|---|
| breast cancer | - | Des.TrialAppr. |
| cervical cancer | - | Des.TrialAppr. |
| ovarian cancer | - | Des.TrialAppr. |
| primary cutaneous T-cell non-Hodgkin lymphoma | lacutamab | Des.TrialAppr. |
0% of portfolio targets high unmet need diseases
60
overlap in 2+ diseases
0/4
candidate diseases
1
avg importance: 70
1
affecting portfolio
0% of portfolio targets high unmet need diseases
60
overlap in 2+ diseases
0/4
candidate diseases
1
avg importance: 70
1
affecting portfolio